Drug reference
ixekizumab
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Drug class
Miscellaneous (Monoclonal Antibodies)
Mechanism of action
Humanized monoclonal IgG4 antibody that targets interleukin-17A (IL-17A) and neutralizes the proinflammatory effects of IL-17A
IL-17A is a naturally occurring cytokine that is involved in normal inflammatory and immune responses and plays a key role in the pathogenesis of plaque psoriasis
Common side effects
- Nausea
- Thrombocytopenia
- Serious infections
- Injection site reacation
- Tinea infections
- Upper respiratory tract infections
Contraindications
- Hypersensitivity reaction (eg, anaphylaxis) to drug or excipients
Related conditions
Frequently asked questions
What drug class is ixekizumab?
ixekizumab belongs to: Miscellaneous.
How does ixekizumab work?
Humanized monoclonal IgG4 antibody that targets interleukin-17A (IL-17A) and neutralizes the proinflammatory effects of IL-17A IL-17A is a naturally occurring cytokine that is involved in normal inflammatory and immune responses and plays a key role in the pathogenesis of plaque psoriasis
What are the common side effects of ixekizumab?
Nausea, Thrombocytopenia, Serious infections, Injection site reacation, Tinea infections, Upper respiratory tract infections
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.